If youve been doing any resistance exercise, you may be gaining some muscle while losing fat
Marty et al., 2020
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) demonstrate glucose-lowering, weight-reducing, and favourable anti-inflammatory and metabolic effects.1 These emerging drug classes have been proven to reduce cardiovascular events in patients with type 2 diabetes mellitus (T2DM) who are at high cardiovascular risk or have established cardiovascular disease.2 In this context, current guidelines recommend GLP-1RAs as first-line antidiabetic therapies in patients with established cardiovascular disease or high/very high cardiovascular risk.3 Semaglutide is a potent GLP-1RA used in the treatment of T2DM, with demonstrated cardiovascular benefits
Because of its antioxidant properties, MTZ exerts chemoprotective effects on DNA damage and OS induced by cisplatin in the rat brain, as proven by decreased MDA, MPO, and 8-OH-GUA levels and increased GSH levels (Gulec et al
The intervention was associated with improvements in cognition, adaptive functioning, social motivation, attention, and motor coordination
